in the era of CER
...real world evidence and AI
The “4th-Hurdle” is the process of achieving market access and reimbursement for biotech innovation. Regulatory agencies and Payers now require effective treatments beyond the first three hurdles of safety, efficacy, and quality.
At 4TH HURDLE AI we are integrating through convergence, artificial intelligence, real-world evidence and digital platforms.
We partner with diagnostic and medical device clients to engage and educate healthcare professionals & payers on potential treatment options for their patients. These options are focused on speeding decision-making and maximizing revenue.
As life sciences companies look to transform their product development pipelines and product lifecycles, AI will lead the revolution in driving a new models for HCP and Payer engagement.